Jane Miskovic-Wheatley

Dr. Jane Miskovic-Wheatley


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2023 in Journal of Eating Disorders
Verified
Journal Article
Open access
JMJane Miskovic-Wheatley
Jane Miskovic-Wheatley
EBEmma Bryant
Emma Bryant
SOShu Hwa Ong
Shu Hwa Ong
SVSabina Vatter
Sabina Vatter
ALAnvi Le
Anvi Le
MWMichelle Williams
Michelle Williams
Background: Eating disorders (ED), especially Anorexia Nervosa (AN), are internationally reported to have amongst the highest mortality and suicide rates in mental health. With limited evidence for current pharmacological and/or psychological treatments, there is a grave responsibility within health research to better understand outcomes for people with a lived experience of ED, factors and interventions that may reduce the detrimental impact of illness and to optimise recovery. This paper aims to synthesise the literature on outcomes for people with ED, including rates of remission, recovery and relapse, diagnostic crossover, and mortality.Methods: This paper forms part of a Rapid Review series scoping the evidence for the field of ED, conducted to inform the Australian National Eating Disorders Research and Translation Strategy 2021–2031, funded and released by the Australian Government. ScienceDirect, PubMed and Ovid/MEDLINE were searched for studies published between 2009 and 2022 in English. High-level evidence such as meta-analyses, large population studies and Randomised Controlled Trials were prioritised through purposive sampling. Data from selected studies relating to outcomes for people with ED were synthesised and are disseminated in the current review.Results: Of the over 1320 studies included in the Rapid Review, the proportion of articles focused on outcomes in ED was relatively small, under 9%. Most evidence was focused on the diagnostic categories of AN, Bulimia Nervosa and Binge Eating Disorder, with limited outcome studies in other ED diagnostic groups. Factors such as age at presentation, gender, quality of life, the presence of co-occurring psychiatric and/or medical conditions, engagement in treatment and access to relapse prevention programs were associated with outcomes across diagnoses, including mortality rates.Conclusion: Results are difficult to interpret due to inconsistent study definitions of remission, recovery and relapse, lack of longer-term follow-up and the potential for diagnostic crossover. Overall, there is evidence of low rates of remission and high risk of mortality, despite evidence-based treatments, especially for AN. It is strongly recommended that research in long-term outcomes, and the factors that influence better outcomes, using more consistent variables and methodologies, is prioritised for people with ED.

20 November 2024 in Journal of Eating Disorders
Verified
Journal Article
Open access
PDF file
LCLaurence Cobbaert
Laurence Cobbaert
AMAnna Rose Millichamp
Anna Rose Millichamp
RERosiel Elwyn
Rosiel Elwyn
SSScout Silverstein
Scout Silverstein
KSKai Schweizer
Kai Schweizer
JMJane Miskovic-Wheatley
Jane Miskovic-Wheatley
Autistic people and those with attention deficit hyperactivity disorder are at a high risk of developing an eating disorder. While there is limited evidence on the relationship between other forms of neurodivergence and eating disorders, research suggests associations between giftedness, intellectual disability, obsessive–compulsive disorder, psychosis, Tourette’s syndrome, and disordered eating. Factors underlying disordered eating and/or eating disorder risk for neurodivergent people are multifaceted and complex, encompassing a wide range of intertwined psychosocial, environmental, and biological processes. Moreover, research shows that neurodivergent individuals experience poorer treatment outcomes compared to neurotypical individuals. However, there is a paucity of research in this area overall. More specifically, lived experience-led research remains rare, despite its critical role for improving individualised eating disorder care, as well as mental healthcare more broadly. Indeed, the importance of eating disorder care individuation is increasingly being recognised, particularly within the context of neurodivergence, given the heterogeneous experiences and support needs of neurodivergent people affected by disordered eating and/or eating disorders. Furthermore, despite documented overlaps between various forms of neurodivergence (e.g., co-occurring autism and attention deficit hyperactivity disorder), research looking at eating disorders in the context of neurodivergence through a transdiagnostic perspective is scarce. This lived experience-led narrative review aims to shed light on the intersectional factors underlying elevated disordered eating and/or eating disorder risk for neurodivergent individuals. First, an overview of prevalence data is provided, followed by a thematic framework identifying factors underlying disordered eating and/or eating disorder risk in relation to neurodivergence. A critical appraisal of current eating disorder research and care is then offered before suggestions for neurodiversity-affirming eating disorder care are made. In this view, this paper offers a foundation for future empirical work in this nascent field of inquiry by providing a lived experience-led, transdiagnostic, and intersectional account of eating disorders in the context of neurodivergence.

17 January 2022 in Journal of Eating Disorders
Verified
Journal Article
Open access
PDF file
JMJane Miskovic-Wheatley
Jane Miskovic-Wheatley
EKEyza Koreshe
Eyza Koreshe
MKMarcellinus Kim
Marcellinus Kim
RSRachel Simeone
Rachel Simeone
SMSarah Maguire
Sarah Maguire
Objective: People with lived experience of eating disorders (ED) may be particularly vulnerable to the COVID-19 pandemic and associated public health response due to exasperating situations such as social isolation, presence of other mental and physical health conditions, disruptions to treatment, etc. This study investigates the association of the pandemic with ED symptomatology to consider impact and identify risk factors for clinical consideration. Methods: Participants with self-reported ED diagnosis and/or symptomatology over 16 years were invited to complete an online survey during the first months of the pandemic in Australia. Questions included history of ED, occurrence of co-occurring mental health conditions, change in ED symptoms since the start of the pandemic, and validated measures of ED illness, state mental health and loneliness. Results: Of 1723 participants (mode age 24.9 years, 91.6% identifying as female, EDE-Q Global Score x = 4.08, SD = 1.18, 79.0% reporting co-occurring mental health condition, predominantly obsessive–compulsive disorder and/or anxiety), 88.0% reported an increase in body image concerns, 74.1% in food restriction, 66.2% binge eating and 46.8% driven exercise during the pandemic. Increased ED symptomatology was associated with poorer state mental health (i.e., depression, anxiety, and stress) and loneliness across the ED symptom profile. Most participants were negatively impacted by various aspects of the public health response, more so for those with more acute ED illness as measured by the Eating Disorder Examination Questionnaire (EDE-Q). Conclusions: Associated with the COVID-19 pandemic is a mental health crisis, particularly for those with a lived experience of an eating disorder. With 40.5% of participants not having sought formal diagnostic assessment and less than half in treatment, this study provides evidence for the detrimental impact of the pandemic on people with a lived experience of an eating disorder, especially for those not yet supported by the health care system.

9 October 2023 in Psychiatry Research
Verified
Journal Article
Open access
SBSarah Barakat
Sarah Barakat
ABAmy L. Burton
Amy L. Burton
MCMichelle Cunich
Michelle Cunich
PHPhillipa Hay
Phillipa Hay
JHJessica Hazelton
Jessica Hazelton
SMSarah Maguire
Sarah Maguire
High dropout rates and poor adherence associated with digital interventions have prompted research into modifications of these treatments to improve engagement and completion rates. This trial aimed to investigate the added benefit of clinician support when paired alongside a ten-session, online cognitive behaviour therapy (CBT) self-help intervention for bulimia nervosa (BN). As part of a three-arm, phase II randomised controlled trial, 114 participants (16 years or over) with full or subthreshold BN were randomly assigned to complete the intervention in a self-help mode (with administrative researcher contact; n = 38), with adjunct clinician support (weekly 30-minute videoconferencing sessions; n = 37), or a no-treatment waitlist control (WLC; n = 39). Baseline to post-treatment (12-weeks) decreases in objective binge episode frequency were significantly greater for clinician-supported participants as compared to WLC, but not for self-help when compared to WLC. However, due to continued improvements for self-help across follow-up (24-weeks), both arms outperformed WLC when analysed as an overall rate of change across three timepoints. Clinician-supported participants outperformed self-help in regards to laxative use and dietary restraint. Our results demonstrate that good clinical outcomes can be achieved with a relatively brief online CBT-based program even in the absence of structured clinical support, indicating a possible overreliance upon clinician support as a primary adherence-facilitating mechanism.

14 November 2024 in International Journal of Eating Disorders
Verified
Journal Article
Open access
MAMoin Uddin Ahmed
Moin Uddin Ahmed
DIDeen Islam
Deen Islam
PAPhillip Aouad
Phillip Aouad
JMJane Miskovic-Wheatley
Jane Miskovic-Wheatley
STStephen Touyz
Stephen Touyz
MCMichelle M Cunich
Michelle M Cunich
Objective: This systematic review aims to comprehensively examine up‐to‐date evidence on the economic burden of eating disorders (EDs), both globally and by region.Methodology: A comprehensive search within five electronic databases, MEDLINE, Embase, CINAHL, PsycINFO, and EconLit, retrieved studies published from August 1, 2013, to June 30, 2024. Cost of illness (COI) studies, burden of disease, and other cost studies that reported costs in monetary values were included, and cost‐effectiveness analysis studies were excluded. The quality of COI studies was assessed using Schnitzler's checklist. All cost estimates were converted into 2024 USD purchasing power parity (PPP). The PROSPERO registration number is CRD42022358136.Findings: Twenty‐six studies were identified for inclusion in this review, with 11 COI studies. The nationwide annual financial cost of EDs is estimated at PPP‐USD 70.5 billion. Indirect costs contributed 70%–93% of total financial costs in the reviewed studies. Intangible costs (burden of disease) were estimated to be PPP‐USD 355.6 billion. About half of the COI studies met 60% of the elements of Schnitzler's checklist, either completely or partly.Discussion: The number of COI studies has more than doubled in the last 10 years. Findings can inform healthcare administrators/policymakers to understand the magnitude of this burden when setting healthcare priorities and allocating resources to maximize social welfare. However, there are variations in the methods (thus quality) and perspectives used to assess this economic burden. Findings suggest that there is potential for enhancing the methodological rigor of future research.

11 July 2025 in International Journal of Eating Disorders
Verified
Journal Article
Open access
JMJane Miskovic-Wheatley
Jane Miskovic-Wheatley
SVSabina Vatter
Sabina Vatter
SOShu Hwa Ong
Shu Hwa Ong
BCBronny Carroll
Bronny Carroll
STStephen Touyz
Stephen Touyz
SMSarah Maguire
Sarah Maguire
Objective: There is a growing demand in health research and policy to meaningfully involve people with lived experience in co‐creating research and treatment services, especially in eating disorders. Despite decades of research into risk, origin, onset, progression, and intervention, significant knowledge gaps remain. The aim of this review was to investigate evidence in the published literature of lived experience consideration and integration in eating disorder research methodology to date.Method: A scoping review methodology was used to review research across six databases. Lived experience was engaged in research ideation, search strategy, and analysis.Results: The search generated over 6553 articles with 76 meeting the inclusion criteria. There has been growth of lived experience research inclusion over the past 5 years, especially in the United Kingdom and Australia. There was a wide range of lived experience engagement from one‐off opportunistic engagement to full project integration and substantial variety in methodological reporting, including terminology, detail, and knowledge‐sharing to advance the field. Researcher reflexivity reporting was rare and lived experience descriptions were sometimes limited by methodology (such as anonymous surveys), compromising analysis of representativeness.Discussion: While research incorporating lived experience is increasing, meaningful engagement varies widely, detailed methodological descriptions are lacking, and guidance on practical implementation is limited. Prioritizing time, resources, and trust‐building in lived experience research and amplifying the value of seeking and reporting such efforts in grant calls and published research has the potential to address knowledge gaps and improve outcomes.